Dr. Maria Theodoulou, formerly of Memorial Sloan Kettering Cancer Center, in New York City, Joins Region’s Largest Cancer Care Provider
ALBANY, NY – New York Oncology Hematology, the region’s largest provider of cancer care, welcomes Maria Theodoulou, MD, formerly of Memorial Sloan Kettering Cancer Center in New York, to its breast cancer team. Dr. Theodoulou is recognized internationally for her breast cancer research and will be seeing patients at NYOH’s Patroon Creek location.
“Having Dr. Theodoulou join our breast cancer team is good for our patients, but also beneficial to the entire medical community,” said Ira Zackon, MD, President, NYOH. “She will be treating patients and providing second opinions, but also attending tumor boards at area hospitals and speaking on her research at the national and international level.”
Dr. Theodoulou is no stranger to NYOH or to the region. During her time at Memorial Sloan Kettering Cancer Center, she saw many NYOH patients from the Capital Region, sharing care, confirming diagnoses and participating in treatment strategies with NYOH’s team of physicians.
She has also lectured extensively in the area, including Albany and Glens Falls. In choosing to relocate from Manhattan to the Western Berkshires, she reached out to Rufus Collea, MD, a breast cancer expert at NYOH, and it was a natural fit to join the team at New York Oncology Hematology.
“Dr. Theodoulou could have gone anywhere, but she chose NYOH,” said Collea, who also serves as the practice’s Medical Director. “She knows – first hand – our physicians’ expertise, commitment to personal care and track record of bringing cutting edge clinical research trials to our patients. We welcome her to our breast cancer team at this exciting time in cancer research and look forward to working together to provide our patients with the most advanced treatment options available.”
Dr. Theodoulou is known internationally for treating both early and advanced stage breast cancer patients, male and female, of all ages. The focus of her research has included novel chemotherapy, biologic and immunotherapy in the treatment of breast cancer. She has also worked extensively in expanding understanding of hormonal agents in both early and advanced stage breast cancer.
A major focus of Dr. Theodoulou’s work has also included the psychological well-being of the total patient, inclusion of family in treatment decisions, patient-focused treatment and the inclusion of all patients, regardless of age, in the discussion of treatment options.
As an attending physician at Memorial Sloan Kettering Cancer Center, Dr. Theodoulou also served as Professor of Medicine at the Joan & Sanford Weill Medical College of Cornell University in New York City. She completed her residency and internship at both Memorial Sloan Kettering Cancer Center and North Shore University Hospital/Cornell University Medical College. She also completed a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Dr. Theodoulou attended State University of New York at Buffalo School of Medicine.
Dr. Theodoulou lives in Manhattan and Hillsdale, NY.
Focused exclusively on the treatment of cancer and blood disorders, NYOH is the largest provider of cancer treatment in the region, with seven conveniently, community-based locations and 33 physicians. NYOH offers the region’s only stem cell transplant program and the largest clinical research program, with more than 40 drug trials currently available to eligible patients.
NYOH continues to grow, having opened its Clifton Park Cancer Center in June, 2015. With Dr. Theodoulou, the practice has hired 10 physicians in the past three years.